Content





 
 

 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Programme for year 2005

Date

Presenter

Status

March 18

Dr. Alexandra Peltier

Download presentation

April 15 Eugène Mutimura Confirmed

April 29         

Miriam Schneidman

Confirmed

May  27  

Dr. Michael Rich           

Confirmed

June 17  

 

 

July ??

Dr. Esquizi           

 

August 19   

Dr. Vyanka Joseph       

Confirmed

September 16

Dr. Kayitesi Kayitankore

Confirmed

October 21

Dr. Louis Munyakazi    

Confirmed

November 18

Dr. Etien Koua              

Confirmed

December 16

TBA

 


Presenters 

Presenter:  Dr Alexandra Peltier

Dr Alexandra Peltier est Assistante technique senior- projet ESTHER (INT 107) au TRAC/ CHUK + RWA 21 pour Lux Development. Elle est Pédiatre infectiologue avec 10 ans d’expérience dans le VIH pédiatrique au CHU Saint-Pierre à Bruxelles (ULB). Elle est diplômée en Médecine tropicale à l’IMT d’Anvers en 1998, et en médecine de catastrophe, soins intensifs et soins d’urgence à l’ULB en 1999-2000. Elle est aussi titulaire d’un DU (Diplôme Universitaire) « Prise en charge de la douleur » à Paris (Saint Antoine). Responsable des Soins d’Urgence pédiatriques au CHU Saint Pierre, elle est aussi Présidente de l’association « Explain AIDS to children ».

Eugene Mutimura
Title: The influence of aerobic exercice on lipodystrophy, metabolic function and quality of life among adults with HIV infection
Eugene Mutimura is a lecturer at Kigali Health Institute. He completed his BSc (Hons) degree and MSc degree from South Africa in 2001. He started his Doctoral studies in 2004 at the University of the Witwatersrand ( South Africa ), with which Kigali Health Institute is establishing a partnership.
 His PhD studies focus on Randomised controlled trial of aerobic capacity on HIV lipodystrophy and metabolic function”, exploring a possible relationship between aerobic exercise capacity, anthropometric variables and metabolic dysfunction that may occur in lipodystrophy syndrome. In response to public health issues, Eugene has attended and presented at several regional & international conferences. He presented papers on HIV/IDS, such as “Response of Higher Institutions of Learning to the HIV/AIDS Pandemic” and “Psycho-Social and Economic Impact of HIV/AIDS on Education System”. He is currently involved in an intervention on “Strategic approaches to HIV/AIDS Prevention, Care & Rehabilitation of People living with HIV/AIDS”. He presented research papers in June 2004 at the 14th International World Confederation for Physical Therapy in Barcelona , Spain (“The role of caregivers in rehabilitation of their children with disabilities” and “Health promotion needs of physically disabled individuals with lower limb amputation in selected areas of Rwanda ”). In 2003 he presented papers in Cape Town on “Public health consequences of landmines in post war Rwanda andPromotion of Health-enhancing programs for physically handicapped individuals”. Responding to the current public outcry of low back pain in Rwanda , he recently completed a research on ‘Low back pain predictors, its classification and patient satisfaction with management.”.
Louis Munyakazi , Ph.D., M.Sc. Ir.
Title: Introduction to the Design and Analysis of Clinical Trials
Louis Munyakazi , Ph.D., M.Sc. Ir. is currently the Director of the Treatment and Research for AIDS Center (TRAC) in Kigali , Rwanda . TRAC is the primary level national agency for HIV/AIDS. As such, he provides leadership in the development of national standards and curriculums for various areas of HIV/AIDS care and research including Care and Treatment, Prevention of Mother to Child Transmission, Voluntary Counseling and Testing, Epidemiology and Monitoring and Evaluation of health sector programs.
Prior to his current position, Dr. Louis was a scientific researcher at Amgen, a leading Biotechnology company in Southern California and a senior statistician at Monsanto, a pharmaceutical company in St-Louis, MO where he took charge of the most challenging projects related to the optimum use of BST, Bovine SomatoTropine hormone. He became uniquely qualified in modeling techniques known as Linear-Plateau Models generally appropriate for growth curves and for evaluation of the stability of field crops. His interests extended to the application of Linear and Non-Linear Mixed Models of Pharmacokinetic data, Repeated Measures designs, Longitudinal or growth data, Calculation of the Minimum Effective Dose (MED) of drug product and its Shelf-life, Application of Principal Components to stability studies, and Partial Least Squares to the data mining for multivariate data. He has shown leadership in statistical support of major projects, including providing assistance to other biostatisticians’ especially in modern statistical techniques such Equivalence Tests, Meta-analysis, Generalized Linear Mixed Models, and Data Mining Techniques.

Etien L. Koua, Ph.D.
Title: GIS and exploratory visualization tools for the exploration of health statistics

Dr. Etien L. Koua is currently a Senior Technical Advisor for Tulane University Payson Center and Acting Chief of TRAC’s Information Technology and Applied Statistics Unit. He holds a PhD in Geoinformatics (Spatial Information Theory and Applied Computer Science, Computational Analysis and Visualization) from the University of Utrecht (The Netherlands).His research interests include Self-organizing Neural Networks, Information Visualization and geovisualization, Data mining and Knowledge Discovery in Databases,

Usability and Human-Computer Interaction. He worked as Research Fellow at the Centre for Telematics and Information technology (CTIT), faculty of computer science at the university of Twente , The Netherlands, and researcher at the International Institute for Geo-information Science and Earth Observation (ITC) in Enschede, The Netherlands. Since 1998, he has been working for Tulane University Payson Center for International Development and Technology Transfer, under a USAID project FHA (Family Health and AIDS) for West and Central Africa and CDC project in Rwanda .  He has been actively involved in operational research, institutional development and capacity building, information systems development, instructional technology, database and GIS development for public health mapping and monitoring in West and Central Africa.

Miriam Schneidman
Title: Using Data for Decision Making
Miriam Schneidman is a Senior Health Specialist in the Human Development Department of the Africa Region of The World Bank.  She holds degrees in Economics from University of Maryland and in Public Health from The Johns Hopkins University.   She has over twenty years of experience at The World Bank on human development issues in Latin America and Africa.  Miriam has written on the subject of vulnerable youth, demographic issues, community financing of health care, health problems of women, and HIV/AIDS.  During the last few years she has been part of a team working on the Bank-funded Multi-Country HIV/AIDS Program (MAP) for Africa and is currently responsible for the Rwanda MAP.  
During the past several years there has been a surge of new epidemiological data and information about the HIV/AIDS epidemic in Africa.  This presentation will discuss key highlights from these new findings, identify ways which this data can be used to inform investments, and discuss some key gaps which remain to be addressed.
Michael L. Rich, MD, MPH
Clinical and Programmatic Aspects of Multidrug-Resistant Tuberculosis (MDR-TB)

A Harvard School of Public Health and University of Massachusetts Medical School alumnus, Michael L. Rich, MD, MPH has been working with Partners in Health (PIH), a charitable organization based at Harvard Medical School bringing TB and HIV treatment to underserved communities.  He has been involved in the largest Multidrug-Resistant Tuberculosis (MDR-TB) treatment program located in Lima , Peru .  

He has helped to treat over 2000 cases of MDR-TB.  Dr. Rich served in the United States Peace Corps in Cameroon , West Africa, and as a medical doctor with Médecins Sans Frontières in Uzbekistan . Dr. Rich is also a member of the World Health Organization's Green Light Committee of the Working Group on DOTS-Plus for MDR-TB.  The Green light committee gives both access to preferentially low priced second-line drugs to treat MDR-TB and technical support to countries applying for these drugs.  He is the lead author on new WHO guidelines for the management of MDR-TB. In 2005, Dr Rich has moved to Rwanda to help develop a community-based antiretroviral treatment (ART) for two rural areas in Rwanda (Rwinkwavu and Kirehe) based on the PIH treatment models developed in Haiti and Peru . 

Products and reports

                                          Home

                                       Contact us


                                                        Last Update Feb. 2005 - © TRAC ICT/Applied statistics Unit